BIOMAT Database Logo BIOMAT Database Logo

Assessment of response fluctuations in Parkinson's disease by ambulatory wrist activity monitoring. 1993

J J van Hilten, and J F Kabel, and H A Middelkoop, and C G Kramer, and G A Kerkhof, and R A Roos
Department of Neurology, Academic Hospital, Leiden, The Netherlands.

The aim of this study was to examine the influence of response fluctuations with dyskinesia on the 24-h motor activity pattern and measures of diurnal and nocturnal activity and immobility. Motor activity was recorded during 5 successive days in 5 patients with advanced Parkinson's disease (PD) suffering from severe response fluctuations with dyskinesia, as well as in 10 PD patients with a stable levodopa response and 10 healthy subjects. The 24-h motor activity pattern of the patients with response fluctuations provides insight into the relationship between the therapeutic regimen and 1) the frequency and duration of "on" and "off" periods, 2) the severity of the dyskinesias, and 3) the degree of sleep disruption. In accordance with the severity of their motor fluctuations, patients with response fluctuations showed a large intra- and interindividual variability of diurnal motor activity measures. Overall, the nocturnal motor activity measures in the patients with response fluctuations indicated a severely disturbed sleep when compared with the two control groups. Factors as simplicity and the potential to record unrestrained motor activity for several days continuously in all settings, make activity monitoring a welcomed acquisition in the assessment of response fluctuations in PD.

UI MeSH Term Description Entries
D007980 Levodopa The naturally occurring form of DIHYDROXYPHENYLALANINE and the immediate precursor of DOPAMINE. Unlike dopamine itself, it can be taken orally and crosses the blood-brain barrier. It is rapidly taken up by dopaminergic neurons and converted to DOPAMINE. It is used for the treatment of PARKINSONIAN DISORDERS and is usually given with agents that inhibit its conversion to dopamine outside of the central nervous system. L-Dopa,3-Hydroxy-L-tyrosine,Dopaflex,Dopar,L-3,4-Dihydroxyphenylalanine,Larodopa,Levopa,3 Hydroxy L tyrosine,L 3,4 Dihydroxyphenylalanine,L Dopa
D008297 Male Males
D008838 Microcomputers Small computers using LSI (large-scale integration) microprocessor chips as the CPU (central processing unit) and semiconductor memories for compact, inexpensive storage of program instructions and data. They are smaller and less expensive than minicomputers and are usually built into a dedicated system where they are optimized for a particular application. "Microprocessor" may refer to just the CPU or the entire microcomputer. Computers, Personal,Microprocessors,Computer, Personal,Microcomputer,Microprocessor,Personal Computer,Personal Computers
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D008991 Monitoring, Physiologic The continuous measurement of physiological processes, blood pressure, heart rate, renal output, reflexes, respiration, etc., in a patient or experimental animal; includes pharmacologic monitoring, the measurement of administered drugs or their metabolites in the blood, tissues, or urine. Patient Monitoring,Monitoring, Physiological,Physiologic Monitoring,Monitoring, Patient,Physiological Monitoring
D009043 Motor Activity Body movements of a human or an animal as a behavioral phenomenon. Activities, Motor,Activity, Motor,Motor Activities
D009460 Neurologic Examination Assessment of sensory and motor responses and reflexes that is used to determine impairment of the nervous system. Examination, Neurologic,Neurological Examination,Examination, Neurological,Examinations, Neurologic,Examinations, Neurological,Neurologic Examinations,Neurological Examinations
D010300 Parkinson Disease A progressive, degenerative neurologic disease characterized by a TREMOR that is maximal at rest, retropulsion (i.e. a tendency to fall backwards), rigidity, stooped posture, slowness of voluntary movements, and a masklike facial expression. Pathologic features include loss of melanin containing neurons in the substantia nigra and other pigmented nuclei of the brainstem. LEWY BODIES are present in the substantia nigra and locus coeruleus but may also be found in a related condition (LEWY BODY DISEASE, DIFFUSE) characterized by dementia in combination with varying degrees of parkinsonism. (Adams et al., Principles of Neurology, 6th ed, p1059, pp1067-75) Idiopathic Parkinson Disease,Lewy Body Parkinson Disease,Paralysis Agitans,Primary Parkinsonism,Idiopathic Parkinson's Disease,Lewy Body Parkinson's Disease,Parkinson Disease, Idiopathic,Parkinson's Disease,Parkinson's Disease, Idiopathic,Parkinson's Disease, Lewy Body,Parkinsonism, Primary
D002940 Circadian Rhythm The regular recurrence, in cycles of about 24 hours, of biological processes or activities, such as sensitivity to drugs or environmental and physiological stimuli. Diurnal Rhythm,Nyctohemeral Rhythm,Twenty-Four Hour Rhythm,Nycthemeral Rhythm,Circadian Rhythms,Diurnal Rhythms,Nycthemeral Rhythms,Nyctohemeral Rhythms,Rhythm, Circadian,Rhythm, Diurnal,Rhythm, Nycthemeral,Rhythm, Nyctohemeral,Rhythm, Twenty-Four Hour,Rhythms, Circadian,Rhythms, Diurnal,Rhythms, Nycthemeral,Rhythms, Nyctohemeral,Rhythms, Twenty-Four Hour,Twenty Four Hour Rhythm,Twenty-Four Hour Rhythms
D003626 Data Display The visual representation of data via a manufactured system. Information Display,Data Displays,Display, Data,Display, Information,Displays, Data,Displays, Information,Information Displays

Related Publications

J J van Hilten, and J F Kabel, and H A Middelkoop, and C G Kramer, and G A Kerkhof, and R A Roos
Response fluctuations in Parkinson's disease.
September 1990, Neurology,
J J van Hilten, and J F Kabel, and H A Middelkoop, and C G Kramer, and G A Kerkhof, and R A Roos
Sleep disruption in Parkinson's disease. Assessment by continuous activity monitoring.
September 1994, Archives of neurology,
J J van Hilten, and J F Kabel, and H A Middelkoop, and C G Kramer, and G A Kerkhof, and R A Roos
Monitoring of walking in Parkinson's disease: validation of an ambulatory activity monitor.
June 2011, Parkinsonism & related disorders,
J J van Hilten, and J F Kabel, and H A Middelkoop, and C G Kramer, and G A Kerkhof, and R A Roos
Ambulatory motor assessment in Parkinson's disease.
January 2006, Movement disorders : official journal of the Movement Disorder Society,
J J van Hilten, and J F Kabel, and H A Middelkoop, and C G Kramer, and G A Kerkhof, and R A Roos
Quantitative assessment of parkinsonian patients by continuous wrist activity monitoring.
February 1993, Clinical neuropharmacology,
J J van Hilten, and J F Kabel, and H A Middelkoop, and C G Kramer, and G A Kerkhof, and R A Roos
Gait assessment in Parkinson's disease: toward an ambulatory system for long-term monitoring.
August 2004, IEEE transactions on bio-medical engineering,
J J van Hilten, and J F Kabel, and H A Middelkoop, and C G Kramer, and G A Kerkhof, and R A Roos
Ambulatory monitoring of freezing of gait in Parkinson's disease.
January 2008, Journal of neuroscience methods,
J J van Hilten, and J F Kabel, and H A Middelkoop, and C G Kramer, and G A Kerkhof, and R A Roos
Fluctuations in response to treatment for Parkinson's disease.
January 2001, Advances in neurology,
J J van Hilten, and J F Kabel, and H A Middelkoop, and C G Kramer, and G A Kerkhof, and R A Roos
Ambulatory objective assessment of tremor in Parkinson's disease.
January 2001, Clinical neuropharmacology,
J J van Hilten, and J F Kabel, and H A Middelkoop, and C G Kramer, and G A Kerkhof, and R A Roos
Effect of cisapride on response fluctuations in Parkinson's disease.
January 1995, Movement disorders : official journal of the Movement Disorder Society,
Copied contents to your clipboard!